Halozyme Therapeutics Inc (HALO)
46.93
-0.39
(-0.82%)
USD |
NASDAQ |
Dec 20, 16:00
46.95
+0.02
(+0.04%)
After-Hours: 20:00
Halozyme Therapeutics Market Cap: 5.971B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexicon Pharmaceuticals Inc | 258.36M |
| Novavax Inc | 1.396B |
| Kura Oncology Inc | 700.65M |
| TransMedics Group Inc | 2.072B |
| Pulmonx Corp | 243.25M |
Market Cap Related Metrics
| PE Ratio | 15.54 |
| PS Ratio | 6.432 |
| PEG Ratio | 0.2563 |
| Price to Book Value | 13.19 |
| Price to Free Cash Flow | 15.52 |
| Price | 46.93 |
| Earnings Yield | 6.44% |
| PEGY Ratio | 0.2563 |
| Operating PE Ratio | 12.77 |
| Normalized PE Ratio | 16.28 |